Monday, 30 January 2017

In-Depth Review on Global Critical Care Therapeutics Market 2017-2021

Report Global Critical Care Therapeutics Market 2017-2021 is a new market research publication announced by Reportstack. 
Report Outline: Critical care or intensive care is the close monitoring and treatment given to individuals with acute, life-threatening illness or injuries such as shock, burns, accidents, complicated surgeries, sepsis, and severe breathing problems. It usually takes place in an ICU or trauma center. Plasma is the fluid portion of the blood, in which all the blood cells are suspended. It makes up about 55% of the total volume of the blood. The other components such as red blood cell (RBC), white blood cell (WBC), and platelets together comprise the remaining 45% of the blood. Plasma is mainly made up of water, which accounts for about 91% of the total volume.
For detailed report with TOC, please click here ​Global Critical Care Therapeutics Market 2017-2021
Market Growth: The global critical care therapeutics market to grow at a CAGR of 3.62% during the period 2017-2021.
Key vendors • CSL Behring
• Grifols
• Kedrion Biopharma
• Octapharma
• Shire
Other prominent vendors • Abeona Therapeutics
• ADMA Biologics
• Albumedix
• Armetheon
• Asklepios BioPharmaceutical
• Aspen Pharma
• Baxter 
• Bayer HealthCare
• Bio Products Laboratory 
• BioDelivery Sciences
• Biogen Idec
• BioMarin
• Biotest Pharmaceuticals
• Bristol-Myers Squibb
• Catalyst Biosciences
• China Biologic Products
• Cosmo Pharmaceuticals
• Kamada
• King Pharmaceuticals
• Medxbio
• Merck
• Mitsubishi Tanabe Pharma
• Novo Nordisk
• Novozymes
• Portola Pharmaceuticals
• ProMetic Life Sciences
• rEVO Biologics
• Rockwell Medical
• Sanquin
• Shanghai RAAS
• Teva Pharmaceutical
• The Medicines Company
• Thermo Fisher Scientific
• Tianjin SinoBiotech & Beijing Bio-Fortune 
• Ventria Bioscience
Regions Covered: 
• Americas
• APAC
• EMEA
Companies Mentioned
CSL Behring, Grifols, Kedrion Biopharma, Octapharma, Shire, Abeona Therapeutics, ADMA Biologics, Albumedix, Armetheon, Asklepios BioPharmaceutical, Aspen Pharma, Baxter, Bayer HealthCare, Bio Products Laboratory, BioDelivery Sciences, Biogen Idec, BioMarin, Biotest Pharmaceuticals, Bristol-Myers Squibb, Catalyst Biosciences, China Biologic Products, Cosmo Pharmaceuticals, Kamada, King Pharmaceuticals, Medxbio, Merck, Mitsubishi Tanabe Pharma, Novo Nordisk, Novozymes, Portola Pharmaceuticals, ProMetic Life Sciences, rEVO Biologics, Rockwell Medical, Sanquin, Shanghai RAAS, Teva Pharmaceutical, The Medicines Company, Thermo Fisher Scientific, Tianjin SinoBiotech & Beijing Bio-Fortune, Ventria Bioscience.
Contact:
Debora White
Manager - Marketing
Ph: +1-888-789-6604
Reportstack Market Research
###

No comments:

Post a Comment